Data collection in Non-diseased Eyes with Long Axial Length and Development of Software using RS-3000

Not Applicable

• Conditions: Healthy individuals

• Registration Number: JPRN-UMIN000004377
• Lead Sponsor: Kyoto University Graduate School of Medicine

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2010-11-01
• Last Update Posted: 17 October 2023

Recruitment & Eligibility

• Status: Complete: follow-up continuing
• Sex: All
• Target Recruitment: 288

Inclusion Criteria

Not provided

Exclusion Criteria

1) Exclusion criteria regarding systemic disease a)a) Diabetes mellitus b)b) Uncontrollable hypertension c)c) Cerebral infarction, cerebral hemorrhage, cranial nerve neoplasm and other central nervous system diseases affecting vision d)d) Cardiac, hepatic, renal and hematologic diseases, and other moderate to severe complications e)e) During systemic administration of steroid f)f) History of anticancer agent etc. g)g) Optically-stimulated epileptic seizure h)h) Dementia i)i)Life-threatening and Debilitating disease j)j)Subjects who currently (within the past 14 days) take any medication which stimulates photosensitivity (e.g. Visudyne, Ciprofroxacin, Bactrim or doxycycline), and subjects who administer concomitant hydroxychloroquine and chloroquine k)k) Other serious systemic diseases 2) Exclusion criteria regarding ocular disease a)a) History of keratorefractive surgery b)b) History of retinal photocoagulation c)History of intraocular surgeries except cataract surgery that had been operated before 6 months or more of qualifying examination day d)Diabetic retinopathy or any other fundus diseases e)Congenital abnormalities of fundus including optic disc. f)Any corneal disorders that would prevent the applanation tonometry g)Serious external ocular diseases, intraocular or eyelid inflammation or external ocular injuries h)Pathological or degenerative myopia 3) Exclusion criteria regarding qualifying examination. 4) Exclusion criteria regarding OCT imaging Subjects who can or could have any difficulty associated with OCT data acquisition

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
To demonstrate the three-dimensional distribution of macular thickness in Non-diseased Eyes with Long Axial Length by spectral domain optical coherence tomography (SD-OCT), and to evaluate the association between macular thickness and sex, age, axial length, and race.